After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Verona Pharma Plc ADR is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Verona Pharma Plc ADR is $5.54B. A total of 0.77 million shares were traded on the day, compared to an average of 1.39M shares.
In the most recent transaction, Rickard Kathleen A. sold 79,264 shares of VRNA for 8.35 per share on Mar 12 ’25. After the transaction, the Chief Medical Officer now owns 2,608,976 company shares. In a previous transaction on Mar 12 ’25, KATHLEEN RICKARD bought 9,908 shares at 62.70 per share.
Among the insiders who sold shares, ZACCARDELLI DAVID disposed of 640,264 shares on Dec 05 ’24 at a per-share price of $5.01. This resulted in the President and CEO holding 14,367,552 shares of VRNA after the transaction. In another insider transaction, ZACCARDELLI DAVID sold 162,800 shares at $5.01 per share on Dec 06 ’24. Company shares held by the President and CEO now total 14,204,752.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, VRNA has a high of $70.40 and a low of $11.39.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. VRNA’s latest balance sheet shows that the firm has $148.38M in Cash & Short Term Investments as of fiscal 2021. There were $5.81M in debt and $33.42M in liabilities at the time. Its Book Value Per Share was $2.42, while its Total Shareholder’s Equity was $148.00M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VRNA is Buy with a score of 5.00.
